A potential test system for detecting contaminations by bacterial lipoproteins

Veterinary Immunology and Immunopathology

Volumn 145, Issue 1-2, 2012, Pages 66-73

  Farhat, Katja ^a   Ulmer, Artur J ^a   Jungi, Thomas W ^b  

^a RESEARCH CENTER BORSTEL   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Bacterial lipoproteins; Bovine; HEK293 TLR2; IL 8; PAMP; Toll like receptor 2

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM LIPOPROTEIN; HUMAN SERUM ALBUMIN; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; LIPOPROTEIN; OVALBUMIN; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM CONTAMINATION; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOKINE PRODUCTION; ESCHERICHIA COLI; GENETIC TRANSFECTION; NONHUMAN;

ANIMALS; BACTERIAL PROTEINS; CATTLE; CLONE CELLS; HEK293 CELLS; HUMANS; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; LIPOPROTEINS; SERUM ALBUMIN; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TRANSFECTION;

BACTERIA (MICROORGANISMS); BOVINAE; ESCHERICHIA COLI;

EID: 84856531380     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2011.10.009     Document Type: Article

References (58)

1. Bessler W.G., Cox M., Lex A., Suhr B., Wiesmüller K.H., Jung G. Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes. J. Immunol. 2009, 135:1900-1905.
2. Bessler W.G., Jung G. Synthetic lipopeptides as novel adjuvants. Res. Immunol. 1992, 143:548-553.
3. Beutler B., Jiang Z., Georgel P., Crozat K., Croker B., Rutschmann S., Du X., Hoebe K. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu. Rev. Immunol. 2006, 24:353-389.
4. Beutler B., Hoebe K., Du X., Ulevitch R.J. How we detect microbes and respond to them: the Toll-like receptors and their transducers. J. Leukoc. Biol. 2003, 74:479-485.
5. Borsutzky S., Kretschmer K., Becker P.D., Mühlradt P.F., Kirschning C.J., Weiss S., Guzman C.A. The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells. J. Immunol. 2005, 174:6308-6313.
6. Buwitt-Beckmann U., Heine H., Wiesmüller K.H., Jung G., Brock R., Akira S., Ulmer A.J. TLR1- and TLR6-independent recognition of bacterial lipopeptides. J. Biol. Chem. 2006, 281:9049-9057.
7. Buwitt-Beckmann U., Heine H., Wiesmuller K.H., Jung G., Brock R., Ulmer A.J. Lipopeptide structure determines TLR2 dependent cell activation level. FEBS J. 2005, 272:6354-6364.
8. Carpenter S., O'Neill L.A. Recent insights into the structure of Toll-like receptors and post-translational modifications of their associated signalling proteins. Biochem. J. 2009, 422:1-10.
9. Eperon S., De Groote D., Werner Felmayer G., Jungi T.W. Human monocytoid cell lines as indicators of endotoxin. Comparison with rabbit pyrogen and Limulus amoebocyte lysate assay. J. Immunol. Methods 1997, 207:135-145.
10. Farhat K., Riekenberger S., Jung G., Wiesmueller K.-H., Jungi T.W., Ulmer A.J. Identification of full length TLR1 and functional characterization of lipopeptide recognition by bovine TLR2/1 heterodimer. Vet. Res. 2010, 41:34-45.
11. Farhat K., Sauter K.S., Brcic M., Ulmer A.J., Frey J., Jungi T.W. The response of HEK293 cells transfected with bovine TLR2 to established pathogen-associated molecular patterns and to bacteria causing mastitis in cattle. Vet. Immunol. Immunopathol. 2008, 125:326-336.
12. Grabiec A., Meng G., Fichte S., Bessler W., Wagner H., Kirschning C.J. Human but not murine toll-like receptor 2 discriminates between tri-palmitoylated and tri-lauroylated peptides. J. Biol. Chem. 2004, 279:48004-48012.
13. Harada T., Morita T., Iwanaga S., Nakamura S., Niwa M. A new chromogenic substrate method for assay of bacterial endotoxins using Limulus hemocyte lysate. Prog. Clin. Biol. Res. 1979, 29:209-220.
14. Hashimoto M., Tawaratsumida K., Kariya H., Kiyohara A., Suda Y., Krikae F., Kirikae T., Götz F. Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J. Immunol. 2006, 177:3162-3169.
15. Hayashi S., Wu H.C. Lipoproteins in bacteria. J. Bioenerg. Biomembr. 1990, 22:451-471.
16. Hirschfeld M., Kirschning C.J., Schwandner R., Wesche H., Weis J.H., Wooten R.M., Weis J.J. Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J. Immunol. 1999, 163:2382-2386.
17. Hirschfeld M., Ma Y., Weis J.H., Vogel S.N., Weis J.J. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J. Immunol. 2000, 165:618-622.
18. Hoffmann P., Heinle S., Schade U.F., Loppnow H., Ulmer A.J., Flad H.D., Jung G., Bessler W.G. Stimulation of human and murine adherent cells by bacterial lipoprotein and synthetic lipopeptide analogues. Immunobiology 1988, 177:158-170.
19. Hoffmann S., Peterbauer A., Schindler S., Fennrich S., Poole S., Mistry Y., Montag-Lessing T., Spreitzer I., Loschner B., van Aalderen M., Bos R., Gommer M., Nibbeling R., Werner-Felmayer G., Loitzl P., Jungi T., Brcic M., Brugger P., Frey E., Bowe G., Casado J., Coecke S., de Lange J., Mogster B., Naess L.M., Aaberge I.S., Wendel A., Hartung T. International validation of novel pyrogen tests based on human monocytoid cells. J. Immunol. Methods 2005, 298:161-173.
20. Holst O., Müller-Loennies S., Lindner B., Brade H. Chemical structure of the lipid A of Escherichia coli J5. Eur. J. Biochem. 1993, 214:695-701.
21. Jin M.S., Kim S.E., Heo J.Y., Lee M.E., Kim H.M., Paik S.G., Lee H., Lee J.O. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 2007, 130:1071-1082.
22. Kaisho T., Akira S. Toll-like receptor function and signaling. J. Allergy Clin. Immunol. 2006, 117:979-987.
23. Kang J.Y., Nan X., Jin M.S., Youn S.J., Ryu Y.H., Mah S., Han S.H., Lee H., Paik S.G., Lee J.O. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 2009, 31:873-884.
24. Kenny E.F., O'Neill L.A. Signalling adaptors used by Toll-like receptors: an update. Cytokine 2009, 43:342-349.
25. Kirschning C.J., Wesche H., Merrill A.T., Rothe M. Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J. Exp. Med. 1998, 188:2091-2097.
26. Levin J., Bang F. A description of cellular coagulation in the limulus. Bull. Johns Hopkins Hosp. 1964, 15:337-345.
27. Levin J., Bang F. The role of endotoxin in the extracellular coagulation of limulus blood. Bull. Johns Hopkins Hosp. 1964, 115:265-274.
28. Means T.K., Lien E., Yoshimura A., Wang S., Golenbock D.T., Fenton M.J. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J. Immunol. 2007, 163:6748-6755.
29. Medzhitov R., Janeway C.A.J. How does the immune system distinguish self from nonself?. Semin. Immunol. 2000, 12:185-188.
30. Mühlradt P.F., Kiess M., Meyer H., Süssmuth R., Jung G. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J. Exp. Med. 1997, 185:1951-1958.
31. Nakamura J., Shibata K., Hasebe A., Into T., Watanabe T., Ohata N. Signaling pathways induced by lipoproteins derived from Mycoplasma salivarium and a synthetic lipopeptide (FSL-1) in normal human gingival fibroblasts. Microbiol. Immunol. 2002, 46:151-158.
32. Obayashi T., Tamura H., Tanaka S., Ohki M., Takahashi S., Arai M., Masuda M., Kawai T. A new chromogenic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applications. Clin. Chim. Acta 1985, 149:55-65.
33. Omueti K.O., Beyer J.M., Johnson C.M., Lyle E.A., Tapping R.I. Domain exchange between human toll-like receptors 1 and 6 reveals a region required for lipopeptide discrimination. J. Biol. Chem. 2005, 280:36616-36625.
34. Peterbauer A., Eperon S., Jungi T.W., Werner E.R., Werner-Felmayer G. Interferon-gamma-primed monocytoid cell lines: optimizing their use for in vitro detection of bacterial pyrogens. J. Immunol. Methods 2000, 233:67-76.
35. Poltorak A., He X., Smirnova I., Liu M.Y., Huffel C.V., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088.
36. Poole S., Thorpe R., Meager A., Gearing A.J. Assay of pyrogenic contamination in pharmaceuticals by cytokine release from monocytes. Dev. Biol. Stand. 1988, 69:121-123.
37. Probey T.F., Pittman M. The pyrogenicity of bacterial contaminants found in biological products. J. Bateriol. 1945, 50:397-411.
38. Rafferty B., Mower J.A., Taktak Y.S., Poole S. Measurement of cytokine production by the monocytic cell line Mono Mac 6 using novel immunoradiometric assays for interleukin-1 beta and interleukin-6. J. Immunol. Methods 1991, 144:69-76.
39. Rezvan M., Grau T., Tschumi A., Sander P. Lipoprotein synthesis in mycobacteria. Microbiology 2007, 153:652-658.
40. Sauter K.S., Brcic M., Franchini M., Jungi T.W. Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS. Vet. Immunol. Immunopathol. 2007, 118:92-104.
41. Schröder N.W., Opitz B., Lamping N., Michelsen K.S., Zähringer U., Göbel U.B., Schumann R.R. Involvement of lipopolysaccharide binding protein, CD14, and Toll-like receptors in the initiation of innate immune responses by Treponema glycolipids. J. Immunol. 2000, 165:2683-2693.
42. Schwandner R., Dziarski R., Wesche H., Rothe M., Kirschning C.J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 1999, 274:17406-17409.
43. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu. Rev. Immunol. 2003, 21:335-376.
44. Takeuchi O., Hoshino K., Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 2000, 165:5392-5396.
45. Takeuchi O., Kawai T., Mühlradt P.F., Morr M., Radolf J.D., Zychlinsky A., Takeda K., Akira S. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 2001, 13:933-940.
46. Takeuchi O., Sato S., Horiuchi T., Hoshino K., Dong Z., Modlin R.L., Akira S. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 2002, 169:10-14.
47. Taktak Y.S., Selkirk S., Bristow A.F., Carpenter A., Ball C., Rafferty B., Poole S. Assay of pyrogens by interleukin-6 release from monocytic cell lines. J. Pharm. Pharmacol. 1991, 43:578-582.
48. Teller J.D., Kelly K.M. A turbidimetric Limulus amoebocyte assay for the quantitative determination of Gram negative bacterial endotoxin. Prog. Clin. Biol. Res. 1979, 29:423-433.
49. Thoma-Uszynski S., Stenger S., Takeuchi O., Ochoa M.T., Engele M., Sieling P.A., Barnes P.F., Röllinghoff M., Bölcskey P.L., Wagner M., Akira S., Norgard M.V., Belisle J.T., Godowski P.J., Bloom B.R., Modlin R.L. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 2001, 291:1544-1547.
50. Timm M., Hansen E.W., Moesby L., Christensen J.D. Utilization of the human cell line HL-60 for chemiluminescence based detection of microorganisms and related substances. Eur. J. Pharmaceut. Sci. 2009, 27:252-258.
51. Travassos L.H., Girardin S.E., Philpott D.J., Blanot D., Nahori M.A., Werts C., Boneca I.G. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep. 2004, 5:1-7.
52. Werling D., Hope J.C., Howard C.J., Jungi T.W. Differential production of cytokines, reactive oxygen and nitrogen by bovine macrophages and dendritic cells stimulated with Toll-like receptor agonists. Immunology 2004, 111:41-52.
53. Werling D., Piercy J., Coffey T.J. Expression of Toll-like receptors (TLR) by bovine antigen-presenting cells - potential role in pathogen discrimination?. Vet. Immunol. Immunopathol. 2006, 112:2-11.
54. Werner-Felmayer G., Baier Bitterlich G., Fuchs D., Hausen A., Murr C., Reibnegger G., Werner E.R., Wachter H. Detection of bacterial pyrogens on the basis of their effects on gamma interferon-mediated formation of neopterin or nitrite in cultured monocyte cell lines. Clin. Diagn. Lab. Immunol. 1995, 2:307-313.
55. Werts C., Tapping R.I., Mathison J.C., Chuang T.H., Kravchenko V., Saint Girons I., Haake D.A., Godowski P.J., Hayashi F., Ozinsky A., Underhill D.M., Kirschning C.J., Wagner H., Aderem A., Tobias P.S., Ulevitch R.J. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat. Immun. 2001, 2:286-288.
56. Wu H.C., Tokunaga M., Tokunaga H., Hayashi S., Giam C.Z. Posttranslational modification and processing of membrane lipoproteins in bacteria. J. Cell Biochem. 1983, 22:161-171.
57. Zähringer U., Lindner B., Inamura S., Heine H., Alexander C. TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 2008, 213:205-224.
58. Ziegler G., Harhausen D., Schepers C., Hoffmann O., Röhr C., Prinz V., König J., Lehrach H., Nietfeld W., Trendelenburg G. TLR2 has a detrimental role in mouse transient focal cerebral ischemia. Biochem. Biophys. Res. Commun. 2007, 359:574-579.